Document Details
Form
Filing Date
May 29, 2019
Document Date
May 24, 2019
Form Description
Statement of changes in beneficial ownership of securities
Filing Group
3,4,5
Company
Arrowhead Pharmaceuticals Inc.
Issuer
ARROWHEAD PHARMACEUTICALS, INC.
Filer
Anzalone Christopher Richard